课题基金 / 基金详情

GNOTOBIOTIC RATS TO STUDY BREAST VERSUS FORMULA MILKS

GNOTOBIOTIC RATS TO STUDY BREAST VERSUS FORMULA MILKS
用知生大鼠研究母乳与配方奶
批准号:
2026717
负责人:
ROBERT James CARMAN
金额:
$8.53万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-06-01 至 1997-11-30

项目摘要

项目成果

ROBERT James CARMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
On days 1 to 3 germfree rats (4 groups, 6 per sex per group) will be seeded with feces from breast fed babies. Each group will be housed in a separate positive pressure isolator. From day 1 animals will be fed the following; 1) human breast milk, 2) Enfamil(tm) milk formula, 3) Enfamil(tm) milk formula supplemented with fructooligosaccharides (FOS: 5% wt/wt) and 4) standard chow. On days 1 (pre-seeding), 5, 9 and 13 freshly voided feces from each animals will be collected and the bifidobacteria, lactobacilli and clostridian will be grown and counted. On day 17 the rats will be killed. Their hindgut contents will be removed and tested as follows: 1) pH, 2) percent water, 3) bacterial cellular fatty acids, 4) short chain fatty acids, 5) bile acid metabolism 6) neutral sterol metabolism, 7) four bacterial enzymes (beta glucosidase, beta glycosidase, azoreductase and nitroreductase) and 8) quantitative PCR probing for 10 key species, and lastly, 9) bacterial counts on a 12 selective and/or differential media. How well FOS convert a formula-fed flora to its more desirable breast-fed counterpart will be assessed by comparing the results. PROPOSED COMMERCIAL APPLICATION; Germfree rats seeded with human feces, from an infant or an adult, will be used as an in vivo system to screen any orally ingested compound, from infant milk formula to olestra, from antibiotics to fiber.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mucin-degrading microflora for prophylactic antibiotics
  • 批准号:
    7220223
  • 项目类别:
  • 资助金额:
    $27.5万
  • 财政年份:
    2007
  • 负责人:
    ROBERT James CARMAN
  • 依托单位:
Mucin-degrading microflora for prophylactic antibiotics
  • 批准号:
    7416715
  • 项目类别:
  • 资助金额:
    $28.11万
  • 财政年份:
    2007
  • 负责人:
    ROBERT James CARMAN
  • 依托单位:
C. difficile Toxin Membrane Test with Magnetic Particles
  • 批准号:
    6783347
  • 项目类别:
  • 资助金额:
    $24.06万
  • 财政年份:
    2003
  • 负责人:
    ROBERT James CARMAN
  • 依托单位:
CELLULAR FATTY ACIDS FOR MONITORING COLONIC MICROFLORA
  • 批准号:
    2145938
  • 项目类别:
  • 资助金额:
    $3.69万
  • 财政年份:
    1993
  • 负责人:
    ROBERT James CARMAN
  • 依托单位:
国内基金
海外基金
瘤内细菌 Lactobacillus iners 通过 eIF4A2 乳酸化介导肿瘤相关巨噬细胞极 化诱导膀胱癌免疫化疗抵抗的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    吴志明
  • 依托单位:
肠道菌群Lactobacillus来源的吲哚-3- 甲醛对绝经后骨量丢失的保护机制研究
Lactobacillus reuteri调控FTO/CMPK2/NLRP3信号轴介导炎症反应治疗5-FU诱导的口腔粘膜炎的作用研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    邱敬诚
  • 依托单位:
葛根交泰丸调控Lactobacillus介导胆汁酸“肠-肝轴”途径治疗2型糖尿病的机制研究
  • 批准号:
    82305009
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    王文波
  • 依托单位: